Merck helps FDA test blockchain for track and trace by Eric Palmer Thursday, June 13, 2019 There has been a lot of talk about how blockchain technology can better protect the U.S. drug supply chain. Merck intends to test that theory.
Did Biogen learn a big lesson from its past proxy fights? by Eric Sagonowsky Monday, April 29, 2019 After its Alzheimer's drug flop wiped out 30% of Biogen's market cap, the company is adding three new members to its board.
GSK consumer meds leap into Watson-powered smart ads by Beth Snyder Bulik Monday, June 6, 2016 Coming soon: Artificial intelligence-powered ads that can chat. Think IBM’s Watson engine, with ads powered to answer “conversational queries like ‘is this medication right for my son?’"
